# GT Apeiron Therapeutic

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/gt-apeiron-therapeutic

- Industry: Pharmaceuticals
- Headquarters: Shanghai, China
- Total disclosed funding: $27M
- Latest round: Angel (Jun 12, 2019)
- Investors on record: 1

## About

Established in 2019 and based in Shanghai, China,  GT Apeiron Therapeutic is a drug development company that focuses on the development of antitumor drugs via artificial intelligence(AI) technology.

## Funding rounds

- Angel, Jun 12, 2019, $27M — GT Healthcare Capital Partners

## Investors

- GT Healthcare Capital Partners (https://capitalatlas.ai/funds/gt-healthcare-capital-partners) — Angel